Showing results (21-30 of 270) with videos related to
Sort By:
Pageof 27
Viruses|November 25, 2023
Screening Drugs for Broad-Spectrum, Host-Directed Antiviral Activity: Lessons from the Development of Probenecid for COVID-19Ralph A Tripp, David E MartinViruses|December 28, 2021
Immunopathology of RSV: An Updated ReviewHarrison C Bergeron, Ralph A TrippVaccines|September 11, 2019
Original Antigenic Sin and Respiratory Syncytial Virus VaccinesRalph A Tripp, Ultan F PowerViruses|March 26, 2022
Repurposing Probenecid to Inhibit SARS-CoV-2, Influenza Virus, and Respiratory Syncytial Virus (RSV) ReplicationRalph A Tripp, David E MartinViruses|January 25, 2018
Verdinexor Targeting of CRM1 is a Promising Therapeutic Approach against RSV and Influenza VirusesJennifer A Pickens, Ralph A TrippCurrent Topics in Microbiology and Immunology|July 11, 2014
Antiviral effects of inhibiting host gene expressionRalph A Tripp, S Mark TompkinsVaccines|December 6, 2016
Synthetic Biodegradable Microparticle and Nanoparticle Vaccines against the Respiratory Syncytial VirusPatricia A Jorquera, Ralph A TrippExpert Opinion on Investigational Drugs|September 9, 2024
Antiviral agents and therapeutics against respiratory virusesRalph A Tripp, David E MartinMethods in Molecular Biology (Clifton, N.J.)|June 5, 2009
Therapeutic applications of RNAi for silencing virus replicationRalph A Tripp, Stephen Mark TompkinsViruses|April 17, 2020
Vero Cells as a Mammalian Cell Substrate for Human NorovirusKyle V Todd, Ralph A TrippPageof 27